Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Bevacizumab may have a better effect on brain necrosis caused by radiotherapy.This randomized
trial aims to investigate whether bevacizumab may alleviate radiation-induced brain necrosis
in patients with nasopharyngeal carcinoma. The effect will be compared with outcomes in
patients receiving steroid therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University